BioN­Tech dou­bles down on an an­ti­body dis­cov­ery group, scoop­ing up a new team to play for the mR­NA spe­cial­ist

What­ev­er BioN­Tech learned about MAB Dis­cov­ery’s an­ti­body gen­er­a­tor over the past 5 years — and a pair of col­lab­o­ra­tions — it was enough tire kick­ing to make …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER